Running a Cancer Program in 2026: Capital, Operations, and the Job Behind the P&L
Yoel Bakas sits down with Jeff Siupik, a healthcare executive with 35 years in oncology operations and 25 years in oncology leadership. Jeff has put in eight to ten linear accelerators across his career, led oncology programs through every reimbursement shift since the early 1990s, and currently oversees operations across a multi-program system.
The conversation walks through the actual job of an oncology administrator in 2026.
The balance between growth and expense control. Why P&L looks worse before it looks better when a program is in growth mode, and what most administrators are…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.